IL33 and colorectal cancer: In models of transplantable and colitis-associated colorectal cancer, tumor growth reduction induced by IL-33 was abrogated in eosinophil-deficient ΔdblGATA-1 mice, but was restored by adoptive transfer of eosinophils activated with IL-33 ex vivo (52).